PEOPLE ON THE MOVE
Cancer Genetics
DNA-based cancer diagnostics company Cancer Genetics has appointed Mandar Kulkarni Chief Technology Officer for its Indian division.
The firm has sites in Rutherford, New Jersey, and Hyderabad, India.
Kulkarni will report directly to Cancer Genetics CEO, Panna Sharma. His previous work for the company involved offering next-generation sequencing (NGS) tests to research institutions, clinical partners and biopharma companies.
He will now spearhead the development of “an oncology-focused knowledge base that will include genomic information geared toward facilitating the personalization of treatment for Indian populations.” The company hopes the database will also be used to inform and accelerate drug discovery and clinical development.
Before joining Cancer Genetics, India, Kulkarni was head of molecular biology and genomics at Sandor Lifesciences, where his team designed and executed next-generation sequencing, bioinformatics, and microarray initiatives. He was also a senior scientist at M/Z Diagnostics where he developed and clinically validated a diagnostic assay for rapid detection of multi-drug resistant bacterial infections.
(Image: Hyderabad)
